-
https://d1y502jg6fpugt.cloudfront.net/13418/archive/files/7cf9af448f61902f5c452b9357ff9294.pdf?Expires=1712793600&Signature=YS0ivHEZgQ-gO1TZ0nreY6gtmaCTcN%7EVooerGQzqoum1B%7EfSPvfQjgynRaz9JTmDEOA99p7vbatxuB26iBC4NDtuAbT%7EddEFzGcfUVnU4AhZOghztfShK18a-IPvmTahcoKsfoD9OOazW5VPDtHOrNqhPldWYWCbK065RoMfRgjXUMfJ%7E-FTvZ8-YHOC1SOPARV9feyoWGOAADFpaaPkT5enrieCklxVL8wXrLUa9j9uiGvt6fncvEFI-LRpqA3t1WEw%7EPMCufxGnPBJBT9kLTx2meMF4ClLlA0uS8jLb99Xn8UonLtZKv%7EHlIicqUS6NfvRMKAGLwyUBX%7EmW5PC7g__&Key-Pair-Id=K6UGZS9ZTDSZM
6357732145177dcc4e6842511d38aeea
PDF Text
Text
Implementing Oral Chemotherapy Education Sessions at BIDMC Boston and Needham
Cancer Centers – A Pilot Program
Dan Roberts, Christina Cibotti, Mary Yenulovich, Kelsey Trillo, Scott Devlin, Chris Rodrigues, Ayad Hamdan, Rebekah Hartwell, Morgan Smith, Holly Dowling, Meghan Shea, Jessica Zerillo
Introduction/Problem
Results/Progress to Date
Oral chemotherapy is becoming more widely utilized in oncology therapeutics since the advent of tyrosine
kinase inhibitors and their application to a wide variety of cancers, shifting a process once solely
occurring in the clinic to patients’ homes. Given the complex process of administering oral chemotherapy
– including from prescription to disposal – concerns regarding poor adherence and excessive toxicity
have arisen which are supported in the literature. Therefore, we sought to implement an “Initial
Education Session” for patients who are newly prescribed oral chemotherapy at both the BIDMC Boston
Cancer Center and BID Needham Cancer Center.
Aim/Goal
The primary aim of the intervention is to successfully implement an independent, nurse or pharmacist-led
oral chemotherapy education session for the patient. Secondary aims include improving the practice’s
adherence to 2013 ASCO/ONS chemotherapy administration safety standards, specifically Standard 20 A
and B, which were carried through in the updated 2016 standards.
The Team
Sponsor: Ayad Hamdan, MD
Project “Coach”: Chris Rodrigues
BIDMC Cancer Center in Boston Gastrointestinal Oncology Division, BIDMC-Needham Cancer
Center, AllCare Plus at BIDMC Specialty Pharmacy
The Interventions
Successfully implement independent oral chemotherapy teach sessions at BID Boston and Needham
Cancer Centers
Provide an education packet which includes drug-specific information, a personalized drug schedule
calendar, and clinic contact numbers.
Patient will undergo teaching assessment with MOATT teaching tool for patients receiving Oral
Agents for Cancer V1.2
The above figure illustrates the process map for implementing oral chemotherapy education sessions at
both Boston and Needham campuses.
For more information, contact:
Dan Roberts MD, Hematology/Oncology fellow at drobert3@bidmc.harvard.edu
�Implementing Oral Chemotherapy Education Sessions at BIDMC Boston and Needham
Cancer Centers – A Pilot Program
Dan Roberts, Christina Cibotti, Mary Yenulovich, Kelsey Trillo, Scott Devlin, Chris Rodrigues, Ayad Hamdan, Rebekah Hartwell, Morgan Smith, Holly Dowling, Meghan Shea, Jessica Zerillo
More Results/Progress to Date
Lessons Learned
The new specialty pharmacy, AllCare, which has recently become available to the BIDMC Cancer
Center at Boston and Needham illustrated the challenge of implementing an intervention that crosses
multiple disciplines with many providers. However, it also has brought us lucrative new resources
and opened up opportunities for making the process more efficient with direct communication with the
approval process between the pharmacy and provider teams.
Next Steps
Begin implementation in the Boston GI Medical Oncology division during the month of March 2018
Successfully incorporate our designated pharmacist from AllCare into the education sessions in
Boston along with the GI nurse coordinators.
Solidify our process for booking the teach sessions in Boston with nursing and administrative
leadership.
Obtain “capture rate” of all new oral chemotherapy prescriptions being referred for formal teach
sessions.
We would like to thank the Massachusetts Society for Clinical Oncologists for the Quality and Innovation
Grant which has allowed this work to be undertaken.
The above figure depicts the percent of each ASCO/ONS oral chemotherapy standard documented in the
BIDMC online medical record before and after the intervention of patients undergoing an independent
education session. The “X” above four of the bars indicate no available data. The documentation of
standards has improved when compared to our rates found in QOPI data for all categories except
“Schedule/Start date”. Major improvements were seen in discussing safe handling, plan for missed doses,
and giving clinic contact instructions.
For more information, contact:
Dan Roberts MD, Hematology/Oncology fellow at drobert3@bidmc.harvard.edu
�
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Silverman Symposium
Description
An account of the resource
Each year the Silverman Symposium poster session offers BIDMC staff and affiliates the opportunity to share experiences and learn about efforts to improve Quality and Safety.
Date
A point or period of time associated with an event in the lifecycle of the resource
2021
Silverman Poster
Primary Contact
If you would like more information about this project, contact this person. Make email address clickable.
Dan Roberts (<a href="mailto:drobert3@bidmc.harvard.edu">drobert3@bidmc.harvard.edu</a>)
Department
Any departments listed on the poster or identified in the spreadsheet.
Hematology/Oncology
Project Team
Dan Roberts
Christina Cibotti
Mary Yenulovich,
Kelsey Trillo
Scott Devlin
Chris Rodrigues
Ayad Hamdan
Rebekah Hartwell
Morgan Smith
Holly Dowling
Meghan Shea
Jessica Zerillo
BIDMC Cancer Center in Boston Gastrointestinal Oncology Division
BID-Needham Cancer Center
AllCare Plus at BIDMC Specialty Pharmacy
BIDMC Location
The BIDMC location where the poster team resides if identified in spreadsheet. If not identified, choose BIDMC.
BIDMC
Dublin Core
The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/.
Title
A name given to the resource
Implementing Oral Chemotherapy Education Sessions at BIDMC Boston and Needham Cancer Centers: A Pilot Program
Date
A point or period of time associated with an event in the lifecycle of the resource
2018
Format
The file format, physical medium, or dimensions of the resource
pdf
Compliance
Effectiveness
Efficiency
Safety
Timeliness